Care of patients undergoing hemodialysis

New England Journal of Medicine

Volumn 339, Issue 15, 1998, Pages 1054-1062

  Ifudu, Onyekachi ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; FLUID BALANCE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; NUTRITION; PATIENT CARE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; TREATMENT FAILURE; VASCULAR ACCESS;

CARDIOVASCULAR DISEASES; GASTROINTESTINAL DISEASES; HEMATOLOGIC DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; PATIENT CARE; RENAL DIALYSIS;

EID: 0032497536     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199810083391507     Document Type: Review

References (62)

1. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Ann Intern Med 1994;121:62-70.
2. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998;338:1428-37.
3. Held PJ, Brunner FP, Odaka M. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 1990;15:451-7.
4. The USRDS Dialysis Morbidity and Mortality Study (Wave 1). In: Renal Data System. USRDS 1996 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, April 1996:45-67.
5. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994;23:661-9.
6. Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 1978;22:347-53.
7. Ifudu O, Mayers JD, Cohen LS, et al. Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients. Am J Nephrol 1996;16:118-23.
8. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-35.
9. Valji K, Bookstein JJ, Roberts AC, Davis GB. Pharmacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: early and late clinical results. Radiology 1991;178:243-7.
10. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfsen M, Humphreys MH. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978;14:491-500.
11. Oh MS, Levison SP, Carroll HJ. Content and distribution of water and electrolytes in maintenance hemodialysis. Nephron 1975;14:421-32.
12. Boddy K, King PC, Lindsay RM, Briggs JD, Winchester JF, Kennedy AC. Total body potassium in non-dialysed and dialysed patients with chronic renal failure. BMJ 1972;1:771-5.
13. Sandle GI, Gaiger E, Tapster S, Goodship TH. Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis. Clin Sci 1987;73:247-52.
14. Linas SL. The role of potassium in the pathogenesis and treatment of hypertension. Kidney Int 1991;39:771-86.
15. Khaw K-T, Barrett-Connor E. Dietary potassium and stroke associated mortality: a 12-year prospective population study. N Engl J Med 1987;316: 235-40.
16. Clausen T, Everts ME. Regulation of the Na,K-pump in skeletal muscle. Kidney Int 1989;35:1-13.
17. Ifudu O, Chan E, Brezsnyak WF, et al. Interdialytic weight gain and missed dialysis treatments in long-term hemodialysis patients. Dial Transplant 1995;24:292-303.
18. Gomez Farices MA, McClellan W, Soucie JM, Mitch WE. A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients. Am J Kidney Dis 1994;23:382-8.
19. de Lemos JA, Hillis LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 1996;7:2044-54.
20. Owen CH, Cummings RG, Sell TL, Schwab SJ, Jones RH, Glower DD. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg 1994;58:1729-33.
21. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119: 484-9.
22. Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 1994;23: 655-60.
23. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992;19:453-9.
24. Charra B, Calemard E, Cuche M, Laurent G. Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 1983;33: 96-9.
25. Ifudu O. The concept of "dry weight" in maintenance hemodialysis: flaws in clinical application. Int J Artif Organs 1996;7:384-6.
26. Lundin AP. Recurrent uremic pericarditis: a marker of inadequate dialysis. Semin Dial 1990;3:5-6.
27. Eschbach JW, Abdulhadi MH, Browne JK, et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease: results of a phase III multicenter clinical trial. Ann Intern Med 1989;111:992-1000.
28. McMahon LP, Dawborn JK. Experience with low dose intravenous and subcutaneous administration of recombinant human erythropoietin. Am J Nephrol 1990;10:404-8.
29. Fishbane S, Maesaka JK. Iron management in end-stage renal disease. Am J Kidney Dis 1997;29:319-33.
30. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996;334:420-5.
31. Geerlings W, Morris RW, Brunner FP, et al. Factors influencing anaemia in dialysis patients: a special survey by the EDTA-ERA Registry. Nephrol Dial Transplant 1993;8:585-9.
32. Madore F, Lowrie EG, Brugnara C, et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 1997; 8:1921-9.
33. Fairbanks VF, Beutler E. Iron deficiency. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams hematology. 5th ed. New York: McGraw-Hill, 1995:490-511.
34. Beamish MR, Davies AG, Eakins JD, Jacobs A, Trevett D. The measurement of reticuloendothelial iron release using iron-dextran. Br J Haematol 1971;21:617-22.
35. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983;308: 8-12.
36. Livio M, Mannucci PM, Viganò G, et al. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 1986; 315:731-5.
37. Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980;93:597-613.
38. Ruiz P, Gomez F, Schreiber AD. Impaired function of macrophage Fcγ receptors in end-stage renal disease. N Engl J Med 1990;322:717-22.
39. Hoy WE, Cestero RV, Freeman RB. Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintenance hemodialysis. Nephron 1978;20:182-8.
40. Garcia-Leoni ME, Martin-Scapa C, Rodeno P, Valderrabano F, Moreno S, Bouza E. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990;9:283-5.
41. al-Homrany M. Successful therapy of tuberculosis in hemodialysis patients. Am J Nephrol 1997;17:32-5.
42. van Geelen JA, Schalm SW, de Visser EM, Heijtink RA. Immune response to hepatitis B vaccine in hemodialysis patients. Nephron 1987;45: 216-8.
43. Delmez JA, Slatopolsky E. Recent advances in the pathogenesis and therapy of uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1991;72:735-9.
44. Malluche HH, Monier-Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 1992;38:S62-S67.
45. Fenves AZ, Emmett M, White MG, Greenway G, Michaels DB. Carpal tunnel syndrome with cystic bone lesions secondary to amyloidosis in chronic hemodialysis patients. Am J Kidney Dis 1986;7:130-4.
46. Weizman R, Weizman A, Levi J, et al. Sexual dysfunction associated with hyperprolactinemia in males and females undergoing hemodialysis. Psychosom Med 1983;45:259-69.
47. Bommer J, Ritz E, del Pozo E, Bommer G. Improved sexual function in male haemodialysis patients on bromocriptine. Lancet 1979;2:496-7.
48. Schaefer RM, Kokot F, Wernze H, Geiger H, Heidland A. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol 1989;31:1-5.
49. Hou S. Frequency and outcome of pregnancy in women on dialysis. Am J Kidney Dis 1994;23:60-3.
50. Ala-Kaila K. Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol 1987;22:372-6.
51. Kang JY, Wu AY, Sutherland IH, Vathsala A. Prevalence of peptic ulcer in patients undergoing maintenance hemodialysis. Dig Dis Sci 1988;33: 774-8.
52. Bazzi C, Pagani C, Sorgato G, Albonico G, Fellin G, D'Amico G. Uremic polyneuropathy: a clinical and electrophysiological study in 135 short- and long-term hemodialyzed patients. Clin Nephrol 1991;35:176-81.
53. Tzamaloukas AH, Avasthi PS. Acid-base disorders in hyperglycemia of insulin-dependent diabetic patients on chronic dialysis. J Diabetes Complications 1988;2:75-8.
54. Rao TKS, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987;316:1062-8.
55. Ifudu O, Mayers JD, Matthew JJ, et al. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s? Am J Kidney Dis 1997;29:549-52.
56. Barth RH. Long survival of chronically dialyzed patients (pts) with HIV disease. J Am Soc Nephrol 1996;7:1439. abstract.
57. Blankestijn PJ, Vos PF, Rabelink TJ, van Rijn HJ, Jansen H, Koomans HA. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 1995;5:1703-8.
58. Pollock CA, Wyndham R, Collett PV, et al. Effects of erythropoietin therapy on the lipid profile in end-stage renal failure. Kidney Int 1994;45: 897-902.
59. Ifudu O, Paul H, Mayers JD, et al. Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis 1994; 23:394-400.
60. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM. Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 1989;9:119-23.
61. Ifudu O, Macey LJ, Friedman EA. Overt malignancy in long-term hemodialysis patients. J Assoc Acad Minor Phys 1997;8:49-51.
62. Ishikawa I. Uremic acquired renal cystic disease: natural history and complications. Nephron 1991;58:257-67.